PHF5A and hepatocellular carcinoma: These outcomes support that PHF5A has a substantial effect on the angiogenic and proliferative state of HCC cells, and thus, patients with high PHF5A expression tend to exhibit an increased response to both antiangiogenic drugs and antiproliferative chemotherapeutic drugs.